Intravenous immunoglobulin treatment in multiple sclerosis
Gadoth, N.; Melamed, E.; Miller, A.; Steiner, I.; Abramsky, O.
Neurology 52(1): 214-215
1999
ISSN/ISBN: 0028-3878 PMID: 9921886 Document Number: 499166
Document emailed within 1 workday
Related Documents
Bykova, O.V.; Nankina, I.A.; Platonova, A.N.; Karpacheva, N.G.; Petrova, O.A.; Gorina, T.P.; Batysheva, T.T.; Serkov, S.V.; Kuzenkova, L.M. 2013: Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10 Pt 2): 61-68Saida, T. 2004: Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis Rinsho Shinkeigaku 44(11): 796-798
Cazzullo, C.L.; Smeraldi, E.; Zibetti, A. 1973: Quantitative analysis of the serum and C.S.F. immunoglobulin fractions in multiple sclerosis Bollettino dell'Istituto Sieroterapico Milanese 52(2): 142-149
Hische, E.A.; van der Helm, H.J.; van Walbeek, H.K. 1982: The cerebrospinal fluid immunoglobulin G index as a diagnostic aid in multiple sclerosis: a Bayesian approach Clinical Chemistry 28(2): 354-355
Rivier, E.; de Crousaz, G.; Steck, A.; Regli, F. 1978: Usefulness of the immunoglobulin-albumin ratio compared to electrophoresis in the diagnosis of multiple sclerosis Schweizerische Medizinische Wochenschrift 108(52): 2066-2068
Tavolato, B. 1972: Immunoglobulin G in cerebrospinal fluid of patients with multiple sclerosis. Study with immunosuppression. Preliminary report Acta Neurologica 27(2): 121-122
Schmidt, S.; Hohlfeld, R. 1995: Current therapy of multiple sclerosis: are there indications for intravenous immunoglobulins? Der Nervenarzt 66(4): 304-307
Fraser, K.B.; Armstrong, M.; Shirodaria, P.V.; Gharpure, M. 1979: Affinity for measles virus anti-haemolysin of a residual immunoglobulin M in sera of some patients with multiple sclerosis Clinical and Experimental Immunology 36(2): 304-310
Caudie, C.; Allauzen, O.; Bancel, J.; Later, R. 2000: Role of isoelectric focusing of cerebrospinal fluid immunoglobulin G in the early biological assessment of multiple sclerosis Annales de Biologie Clinique 58(2): 187-193
Alonso, K.; Medenica, R. 1995: Immunomodulation in the treatment of multiple sclerosis and amyotrophic lateral sclerosis: a model for autoimmune disorders Journal of the National Medical Association 87(8): 561-568
Schanke, A.K.; Grimsmo, J.; Sundet, K. 1995: Multiple sclerosis and prerequisites for driver's licence. A retrospective study of 33 patients with multiple sclerosis assessed at Sunnaas hospital Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(11): 1349-1352
Laosanguanek, N.; Wiroteurairuang, T.; Siritho, S.; Prayoonwiwat, N. 2011: Reliability of the Thai version of SF-36 questionnaire for an evaluation of quality of life in multiple sclerosis patients in multiple sclerosis clinic at Siriraj Hospital Journal of the Medical Association of Thailand 94 Suppl. 1: S84-S88
Reclos, G.J.; Baxevanis, C.N.; Sfagos, C.; Papageorgiou, C.; Tsokos, G.C.; Papamichail, M. 1987: Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis Clinical and Experimental Immunology 70(2): 336-344
Taneichi, H.; Miyawaki, T. 2011: High-dose intravenous immunoglobulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 69(3): 515-519
Ganly, P.; Spearing, R. 2006: Treatment with intravenous immunoglobulin is not a panacea but should be limited to those who can benefit New Zealand Medical Journal 119(1246): U2335
Shih, W.W.; Baumhefner, R.W.; Tourtellotte, W.W.; Haskell, C.M.; Korn, E.L.; Fahey, J.L. 1983: Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis Clinical and Experimental Immunology 53(1): 122-132
Batchelor, J.M.; Todd, P.M. 2012: Treatment of ulcerated necrobiosis lipoidica with intravenous immunoglobulin and methylprednisolone Journal of Drugs in Dermatology: Jdd 11(2): 256-259
Singh, S.; Kumar, L. 1996: Kawasaki disease--treatment with intravenous immunoglobulin during the acute stage Indian Pediatrics 33(8): 689-692
Sangtawesin, C.; Kirawitaya, T.; Layangkool, T.; Nawasiri, W.; Vimolsarawong, N. 2003: Treatment of Kawasaki disease using locally product intravenous immunoglobulin Journal of the Medical Association of Thailand 86(Suppl 3): S656-S660
Sapir, T.; Carp, H.; Shoenfeld, Y. 2005: Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL) Harefuah 144(6): 415